HONG KONG, Sept. 16, 2024 /PRNewswire/ — At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a first-line (1L) treatment for triple-negative breast cancer (TNBC). The…

Mature results from Medivir’s phase 1b / 2a open label trial of fostrox + Lenvima® confirm improved outcomes in second-line advanced liver cancer with a median time to progression (TTP) of 10.9 months1 (4.1 – 18.1). The results showed an objective response (ORR) of 24%, and a median…

VIENNA, Sept. 16, 2024 /PRNewswire/ — Open Source Summit Europe – The Linux Foundation, the nonprofit organization enabling mass innovation through open source, welcomed free5GC to the Linux Foundation community. The free5GC is an open source project for fifth-generation (5G) mobile core…

BEIJING, Sept.16, 2024 /PRNewswire/ — ForwardX Robotics, Asia’s largest vision-based AMR solution provider, is proud to announce its strategic partnership with Optiscan Group as its official distributor in Finland and the rest of the Nordic region. This collaboration represents a…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.